Group One Trading
INSY

Group One Trading’s Insys Therapeutics, Inc. INSY Stock Holding History

Group One Trading’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,460
Closed -$53K – 5713
2019
Q1 		$53K Buy
+11,460
New +$54.3K ﹤0.01% 3542
2018
Q4 		– Sell
-5,931
Closed -$41.2K – 5777
2018
Q3 		$60K Sell
5,931
-2,555
-30% -$20.4K ﹤0.01% 3864
2018
Q2 		$61K Buy
+8,486
New +$59.2K ﹤0.01% 3856
2017
Q4 		– Sell
-14,196
Closed -$92.9K – 5493
2017
Q3 		$126K Buy
+14,196
New +$146K ﹤0.01% 3085
2016
Q2 		– Sell
-17,882
Closed -$261K – 5131
2016
Q1 		$286K Buy
+17,882
New +$340K ﹤0.01% 2087
2014
Q2 		– Sell
-8,550
Closed -$138K – 5666
2014
Q1 		$177K Buy
8,550
+3,750
+78% +$74.4K ﹤0.01% 2548
2013
Q4 		$62K Buy
+4,800
New +$66.6K ﹤0.01% 3438

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Group One Trading's INSY Position: Q2 2019 in Review

Group One Trading sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 11,460 shares — an estimated $53K sold.

Group One Trading first reported a position in INSY in Q4 2013 and held it in 7 quarters. The position peaked at $286K in Q1 2016. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Group One Trading reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Group One Trading sold 11,460 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $53K.
  • Group One Trading first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 7 quarters.
  • Group One Trading's Insys Therapeutics, Inc. position peaked at $286K in Q1 2016.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Group One Trading's 13F filing for Q2 2019, filed 9 Aug 2019.